These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1677044)

  • 1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
    Bejanian M; Pechnick RN; Bova MP; George R
    J Pharmacol Exp Ther; 1991 Jul; 258(1):88-93. PubMed ID: 1677044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two subtypes of enteric non-opioid sigma receptors in guinea-pig cholinergic motor neurons.
    Coccini T; Costa LG; Manzo L; Candura SM; Iapadre N; Balestra B; Tonini M
    Eur J Pharmacol; 1991 May; 198(1):105-8. PubMed ID: 1680712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of rat cortical sigma receptors after subchronic administration of rimcazole and 1,3-di(2-tolyl)guanidine.
    Manallack DT; Beart PM
    Neuropharmacology; 1988 Nov; 27(11):1201-3. PubMed ID: 2849732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF; Tam SW; Cook L
    Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats.
    Bastianetto S; Perrault G; Sanger DJ
    Neuropharmacology; 1995 Jan; 34(1):107-14. PubMed ID: 7623959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test.
    Skuza G; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):329-35. PubMed ID: 9566032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-Di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazole.
    Kest B; Mogil JS; Sternberg WF; Pechnick RN; Liebeskind JC
    Pharmacol Biochem Behav; 1995 Sep; 52(1):175-8. PubMed ID: 7501662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus characteristics of BMY 14802 in the pigeon.
    Vanecek SA; Essman WD; Taylor DP; Woods JH
    J Pharmacol Exp Ther; 1998 Jan; 284(1):1-9. PubMed ID: 9435153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(3):327-30. PubMed ID: 8106091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM; O'Shea RD; Manallack DT
    J Neurochem; 1989 Sep; 53(3):779-88. PubMed ID: 2569504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma sites mediate DTG-evoked hypothermia in rats.
    Rawls SM; Baron DA; Geller EB; Adler MW
    Pharmacol Biochem Behav; 2002 Nov; 73(4):779-86. PubMed ID: 12213522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligand.
    Kest B; Mogil JS; Sternberg WF; Pechnick RN; Liebeskind JC
    Pharmacol Biochem Behav; 1995 Apr; 50(4):587-92. PubMed ID: 7617705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A; Smith M; French ED
    Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
    Levant B; Nemeroff CB
    J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B; Burke M; Leonard BE; Gouret CJ; Junien JL
    Brain Res; 1991 Apr; 546(2):282-6. PubMed ID: 1676927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Okumura K; Ujike H; Akiyama K; Kuroda S
    J Neural Transm (Vienna); 1996; 103(10):1153-61. PubMed ID: 9013402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
    Hara H; Tanaka K; Harada Y; Sukamoto T
    J Pharmacol Exp Ther; 1994 May; 269(2):799-805. PubMed ID: 8182548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers.
    Hudzik TJ; De Costa BR; McMillan DE
    Eur J Pharmacol; 1993 May; 236(2):279-87. PubMed ID: 8100532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.